Corebridge Financial (CRBD) adds Nippon Life executive Hirotaka Inoue to board
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Corebridge Financial, Inc. announced governance changes linked to its partnership with Nippon Life Insurance Company. The Board elected Hirotaka Inoue, a Nippon Life designee, as a director effective April 21, 2026, replacing Minoru Kimura, who departs April 20, 2026.
Earlier, the Board reduced its size to eleven members and granted Nippon Life a waiver so it may continue to have three Nippon Life-designated directors despite the new Board size. The Board also determined Mr. Inoue qualifies as an independent director and appointed Nippon Life designee Tomohiro Yao to the Nominating and Corporate Governance Committee.
Mr. Inoue, a senior executive at Nippon Life with experience in global insurance regulation and financial policy, will not receive Board compensation from Corebridge under the Nippon Life Stockholder’s Agreement. Corebridge highlights that it manages more than $385 billion in assets under management and administration as of December 31, 2025.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.02, 7.01, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Board size: 11 directors
Nippon Life designees: 3 directors
Nippon Life ownership threshold: 5%
+2 more
5 metrics
Board size
11 directors
Reduced from 13 on March 25, 2026
Nippon Life designees
3 directors
Number of Nippon Life-designated directors after waiver
Nippon Life ownership threshold
5%
Level below which Nippon Life loses board designation right
Effective date of Inoue election
April 21, 2026
Start of his service as Corebridge director
Assets under management and administration
$385 billion+
As of December 31, 2025
Key Terms
Nippon Life Stockholder’s Agreement, Separation Agreement, independent director, Nominating and Corporate Governance Committee, +1 more
5 terms
Nippon Life Stockholder’s Agreement financial
"Pursuant to the Stockholder’s Agreement (the Nippon Life Stockholder’s Agreement), dated as of December 9, 2024..."
Separation Agreement financial
"AIG waived its right under the Separation Agreement (the Separation Agreement), dated as of September 14, 2022..."
A separation agreement is a written contract that spells out the financial and legal terms when an employee and a company part ways, such as final pay, severance, continued benefits, confidentiality, and any release of claims. For investors, it matters because these agreements determine immediate costs, potential future liabilities, and whether departing staff are restricted from competing or disclosing information—factors that can affect a company’s cash flow, risk profile, and leadership continuity.
independent director financial
"The Board determined that Mr. Inoue qualifies as an independent director under the Corporate Governance Standards..."
An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.
Nominating and Corporate Governance Committee financial
"the Board also appointed Mr. Yao to the Nominating and Corporate Governance Committee of the Board..."
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
Item 404(a) of Regulation S-K regulatory
"he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K."
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 14, 2026
(Exact name of registrant as specified in its charter)
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | |||||||||
| (Address of Principal Executive Offices) | (Zip Code) | ||||||||||
Registrant’s telephone number, including area code: 1-877 -375-2422
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. | ||||
On April 14, 2026, the Board of Directors (the Board) of Corebridge Financial, Inc. (the Company) elected Hirotaka Inoue as a director of the Company, effective April 21, 2026.
Pursuant to the Stockholder’s Agreement (the Nippon Life Stockholder’s Agreement), dated as of December 9, 2024, between the Company and Nippon Life Insurance Company (Nippon Life), until the date that the share ownership percentage of Nippon Life is less than 5%, Nippon Life has the right to designate a number of individuals to serve as directors equal to (a) the product of the total number of Board members multiplied by (b) the share ownership percentage of Nippon Life, with such number of directors rounded down to the nearest whole number (each, a Nippon Life Designee). Keith Gubbay, Minoru Kimura and Tomohiro Yao currently serve on the Board as Nippon Life Designees.
As previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 16, 2026, Nippon Life notified the Company on March 11, 2026 that it will effect a change in one of the Nippon Life Designees, with Mr. Kimura resigning from the Board, effective as of April 20, 2026.
On March 23, 2026, American International Group, Inc. (AIG) waived its right under the Separation Agreement (the Separation Agreement), dated as of September 14, 2022, between the Company and AIG, as amended by that certain Amendment, dated as of May 16, 2024, by and between the Company and AIG (the Amendment) to designate any members of the Board, resulting in a decrease of the number of Board members designated by AIG to zero (0).
On March 25, 2026, the Board decreased the size of the Board to eleven (11) from thirteen (13) members. As a result of such reduction in the size of the Board, Nippon Life is entitled to designate only two (2) Nippon Life Designees to the Board pursuant to the terms of the Nippon Life Stockholder’s Agreement.
On March 25, 2026, the Board determined that it was in the best interest of the Company and its stockholders to grant Nippon Life a waiver in respect of the Board designation provisions of the Nippon Life Stockholder’s Agreement (until such time as revoked by the Board in its discretion) (the Waiver), so that Nippon Life will continue to have three (3), rather than two (2), Nippon Life Designees on the Board. Pursuant to the Waiver, (a) Nippon Life designated Mr. Inoue to replace Mr. Kimura as a Nippon Life Designee and (b) Messrs. Gubbay and Yao will continue to serve on the Board as Nippon Life Designees.
On April 14, 2026, the Board elected Mr. Inoue as a director of the Company, effective on April 21, 2026, to fill the vacancy that will result from Mr. Kimura’s departure on April 20, 2026, and nominated Mr. Inoue to stand for election at the 2026 annual meeting of stockholders of the Company. The Board determined that Mr. Inoue qualifies as an independent director under the Corporate Governance Standards of the New York Stock Exchange. On April 14, 2026, the Board also appointed Mr. Yao to the Nominating and Corporate Governance Committee of the Board, effective as of April 21, 2026.
Pursuant to the Nippon Life Stockholder's Agreement, Mr. Inoue will not be compensated by the Company for his service on the Board. Mr. Inoue has no family relationship with any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
The foregoing description of the Nippon Life Stockholder’s Agreement, the Separation Agreement and the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Nippon Life Stockholder’s Agreement, the Separation Agreement and the Amendment, copies of which are filed as Exhibits 10.60, 10.4 and 10.58, respectively, to the Company’s Annual Report on Form 10-K filed on February 11, 2026 and incorporated by reference herein.
Item 7.01 | Regulation FD Disclosure. | ||||
On April 17, 2026, the Company issued a press release announcing the election of Mr. Inoue to the Board. A copy of
the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly incorporated by reference in such filing.
Item 9.01 | Financial Statements and Exhibits. | ||||
(d) Exhibits
Exhibit No. | Description of Exhibit | |||||||
99.1 | Press release dated April 17, 2026 (furnished herewith and not filed). | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Corebridge Financial, Inc. | ||||||||||||||
| Date: | April 17, 2026 | By: | /s/Jeannette N. Pina | |||||||||||
| Name: | Jeannette N. Pina | |||||||||||||
| Title: | Deputy General Counsel and Secretary | |||||||||||||
 | FOR IMMEDIATE RELEASE | ||||
Corebridge Financial Elects Hirotaka Inoue to Board of Directors
HOUSTON – April 17, 2026 – Corebridge Financial, Inc. (NYSE: CRBG) today announced that its Board of Directors elected Hirotaka Inoue as a director effective April 21, 2026. Mr. Inoue will serve as a Nippon Life Insurance Company-designated director and will replace Minoru Kimura, who will depart from the Board effective April 20, 2026.
“We are pleased to welcome Hirotaka Inoue to the Corebridge Board,” said Alan Colberg, Chair of the Board of Corebridge Financial. “Hiro brings deep expertise in global insurance regulation, financial risk oversight and monetary policy. His extensive experience working with regulators and policymakers around the world will be a valuable asset to Corebridge.”
Mr. Inoue currently serves as Executive Officer and Head of Regulatory and Market Intelligence, Global Business Planning, at Nippon Life Insurance Company. In this role, he is responsible for monitoring global regulatory developments and advising senior management on strategic implications for Nippon Life’s international insurance operations. Prior to joining Nippon Life, Mr. Inoue held a series of senior leadership roles at the Bank of Japan, including positions spanning monetary policy, financial markets and international financial policy, and was seconded to the Financial Stability Board Secretariat.
# # #
About Corebridge Financial
Corebridge Financial, Inc. makes it possible for more people to take action in their financial lives. With more than $385 billion in assets under management and administration as of December 31, 2025, Corebridge Financial is one of the largest providers of retirement solutions and insurance products in the United States. We proudly partner with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. For more information, visit corebridgefinancial.com and follow us on LinkedIn.
Contacts
Işıl Müderrisoğlu (Investors): investorrelations@corebridgefinancial.com
Paul Miles (Media): media.contact@corebridgefinancial.com
FAQ
What board change did Corebridge Financial (CRBD) announce in this 8-K?
Corebridge Financial’s Board elected Hirotaka Inoue as a director effective April 21, 2026, replacing Nippon Life designee Minoru Kimura, who leaves April 20, 2026. Inoue is nominated for election at the company’s 2026 annual stockholders’ meeting.
How does the Nippon Life Stockholder’s Agreement affect Corebridge (CRBD) board seats?
The Nippon Life Stockholder’s Agreement lets Nippon Life designate directors based on its share ownership percentage while it holds at least 5%. After the Board shrank to eleven members, Corebridge granted a waiver so Nippon Life can continue to designate three directors.
Is Hirotaka Inoue considered an independent director at Corebridge (CRBD)?
Yes. The Board determined that Hirotaka Inoue qualifies as an independent director under New York Stock Exchange Corporate Governance Standards. He will serve as a Nippon Life-designated director but, under the Nippon Life Stockholder’s Agreement, will not be compensated by Corebridge for his Board service.
What committee assignment did Tomohiro Yao receive on the Corebridge (CRBD) Board?
The Board appointed Nippon Life designee Tomohiro Yao to the Nominating and Corporate Governance Committee, effective April 21, 2026. This role places him directly in the company’s governance and director nomination processes, reflecting Nippon Life’s continued representation in board-level oversight.
How large is Corebridge Financial’s business according to this filing?
Corebridge Financial reports managing more than $385 billion in assets under management and administration as of December 31, 2025. This positions the company among major U.S. providers of retirement solutions and insurance products serving individuals through financial professionals and institutions.
What change did AIG make regarding Corebridge (CRBD) board designation rights?
On March 23, 2026, American International Group, Inc. waived its contractual right to designate any Corebridge Board members under the Separation Agreement, as amended. This reduced AIG’s designated Board members to zero and preceded the Board’s decision to shrink its size to eleven directors.